首页> 美国卫生研究院文献>Cancer Science >Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in
【2h】

Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in

机译:与激素受体和更年期地位有关的生殖因子和乳腺癌风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The associations between menstrual and reproductive factors and breast cancer risk in relation to estrogen/progesterone receptor (ER/PgR) status have been unclear in Japanese women. This case‐control study evaluated these associations, overall and separately, by menopausal status. A total of 1092 breast cancer cases and 3160 controls were selected from among female patients aged 30 years and over admitted to a single hospital in Miyagi Prefecture between 1997 and 2009. The receptor status distribution among the cases (missing: 8.4%) was 571 ER+/PgR+, 133 ER+/PgR−, 24 ER−/PgR+ and 271 ER−/PgR−. Menstrual and reproductive factors were assessed using a self‐administered questionnaire. Polytomous logistic regression and tests for heterogeneity across ER+/PgR+ and ER−/PgR− were conducted. Later age at menarche was significantly associated with a decreased risk of both ER+/PgR+ and ER−/PgR− cancer among women overall (Ptrend = 0.0016 for ER+/PgR+; Ptrend = 0.015 for ER−/PgR−) and among postmenopausal women (Ptrend = 0.012 for ER+/PgR+; Ptrend = 0.0056 for ER−/PgR−). Nulliparity was associated with an increased risk of ER+/PgR+, but not ER−/PgR− cancer among women overall (Pheterogeneity = 0.019) and among postmenopausal women (odds ratio for ER+/PgR+ = 2.56, 95% confidence interval = 1.61–4.07; Pheterogeneity = 0.0095). A longer duration of breastfeeding tended to be associated with a decreased risk in all subtypes among women overall. Later age at menarche has a protective effect against both ER+/PgR+ and ER−/PgR− cancer. However, parity might impact differently on various subtypes of breast cancer. Further studies are needed to clarify the etiology of the rare ER+/PgR− and ER−/PgR+ cancer subtypes.
机译:在日本女性中,月经和生殖因子和乳腺癌风险与雌激素/黄体酮受体(ER / PGR)状况的关联尚不清楚。这种案例对照研究通过更年期状态进行了总体和分开评估了这些关联。共有1092例乳腺癌病例和3160种对照,均为1997年至2009年间宫崎河县的一家医院的女性患者中选择了3160名对照。案件中的受体状况分布(缺失:8.4%)是571 er + / PGR +,133 ER + / PGR - ,24 er-/ PGR +和271 er-/ PGR-。使用自我管理的问卷评估月经和生殖因素。多元逻辑回归和对ER + / PGR +和ER-/ PGR的异质性的测试。初期的后期年龄与女性总体妇女的ER + / PGR +和ER-/ PGR癌症的风险显着显着相关(PER + / PGR +的趋势= 0.0016; P.趋势= 0.015用于er- / pgr-)和绝经后妇女(pER + / PGR +趋势= 0.012; P.ER-/ PGR-)的趋势= 0.0056。缺斑与ER + / PGR +的风险增加有关,但在整体女性中没有ER-/ PGR-癌症(P异质性= 0.019)和绝经后妇女(ER + / PGR + = 2.56的差距+ = 2.56,95%置信区间= 1.61-4.07; p异质性= 0.0095)。较长的母乳喂养往往与整体女性所有亚型的风险降低有关。月经初期的后期对ER + / PGR +和ER-/ PGR-癌症具有保护作用。然而,奇偶校验可能会影响不同的乳腺癌亚型。需要进一步的研究来阐明罕见的ER + / PGR和ER-/ PGR +癌症亚型的病因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号